【市場調査レポート】抗体検査プラットフォームのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Antibody Discovery Platforms Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。抗体検査プラットフォームのグローバル市場インサイト・予測（～2028年） / Global Antibody Discovery Platforms Market Insights, Forecast to 2028 / QY2207E09219資料のイメージです。

• レポートコード：QY2207E09219
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、111ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の抗体検査プラットフォームの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗体検査プラットフォームの世界市場のxxx％を占める「抗原設計」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医薬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の抗体検査プラットフォームの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの抗体検査プラットフォーム市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの抗体検査プラットフォーム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

抗体検査プラットフォームのグローバル主要メーカーには、Abwiz Bio、Aragen Bioscience、Creative Biolabs、Distributed Bio、ImmunoPrecise Antibodies、Integral Molecular、LakePharma、Syd Labs、Abzena、BIOTEM、PX'Therapeutics、ChemPartner、HD Biosciences、Viva Biotech、WuXi Biologics、Kymab、Ligand Pharmaceuticals、MorphoSysなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

抗体検査プラットフォーム市場は、種類と用途によって区分されます。世界の抗体検査プラットフォーム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
抗原設計、ヒット作製、リード選択、リード最適化、リード特性評価、その他

【用途別セグメント】
医薬、生物学研究所、治療研究、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 抗体検査プラットフォーム製品概要
- 種類別市場（抗原設計、ヒット作製、リード選択、リード最適化、リード特性評価、その他）
- 用途別市場（医薬、生物学研究所、治療研究、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の抗体検査プラットフォーム販売量予測2017-2028
- 世界の抗体検査プラットフォーム売上予測2017-2028
- 抗体検査プラットフォームの地域別販売量
- 抗体検査プラットフォームの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別抗体検査プラットフォーム販売量
- 主要メーカー別抗体検査プラットフォーム売上
- 主要メーカー別抗体検査プラットフォーム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（抗原設計、ヒット作製、リード選択、リード最適化、リード特性評価、その他）
- 抗体検査プラットフォームの種類別販売量
- 抗体検査プラットフォームの種類別売上
- 抗体検査プラットフォームの種類別価格
・用途別市場規模（医薬、生物学研究所、治療研究、その他）
- 抗体検査プラットフォームの用途別販売量
- 抗体検査プラットフォームの用途別売上
- 抗体検査プラットフォームの用途別価格
・北米市場
- 北米の抗体検査プラットフォーム市場規模（種類別、用途別）
- 主要国別の抗体検査プラットフォーム市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの抗体検査プラットフォーム市場規模（種類別、用途別）
- 主要国別の抗体検査プラットフォーム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の抗体検査プラットフォーム市場規模（種類別、用途別）
- 主要国別の抗体検査プラットフォーム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の抗体検査プラットフォーム市場規模（種類別、用途別）
- 主要国別の抗体検査プラットフォーム市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの抗体検査プラットフォーム市場規模（種類別、用途別）
- 主要国別の抗体検査プラットフォーム市場規模（トルコ、サウジアラビア）
・企業情報
Abwiz Bio、Aragen Bioscience、Creative Biolabs、Distributed Bio、ImmunoPrecise Antibodies、Integral Molecular、LakePharma、Syd Labs、Abzena、BIOTEM、PX'Therapeutics、ChemPartner、HD Biosciences、Viva Biotech、WuXi Biologics、Kymab、Ligand Pharmaceuticals、MorphoSys
・産業チェーン及び販売チャネル分析
- 抗体検査プラットフォームの産業チェーン分析
- 抗体検査プラットフォームの原材料
- 抗体検査プラットフォームの生産プロセス
- 抗体検査プラットフォームの販売及びマーケティング
- 抗体検査プラットフォームの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 抗体検査プラットフォームの産業動向
- 抗体検査プラットフォームのマーケットドライバー
- 抗体検査プラットフォームの課題
- 抗体検査プラットフォームの阻害要因
・主な調査結果

Market Analysis and Insights: Global Antibody Discovery Platforms Market
The global Antibody Discovery Platforms market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Antigen Designing accounting for % of the Antibody Discovery Platforms global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Antibody Discovery Platforms market size is valued at US$ million in 2021, while the North America and Europe Antibody Discovery Platforms are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Antibody Discovery Platforms landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antibody Discovery Platforms market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antibody Discovery Platforms market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antibody Discovery Platforms market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antibody Discovery Platforms market.
Global Antibody Discovery Platforms Scope and Market Size
Antibody Discovery Platforms market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Antibody Discovery Platforms market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Antigen Designing
Hit Generation
Lead Selection
Lead Optimization
Lead Characterization
Others
Segment by Application
Pharmaceutical
Institute of Biology
Therapeutic Research
Others
By Company
Abwiz Bio
Aragen Bioscience
Creative Biolabs
Distributed Bio
ImmunoPrecise Antibodies
Integral Molecular
LakePharma
Syd Labs
Abzena
BIOTEM
PX’Therapeutics
ChemPartner
HD Biosciences
Viva Biotech
WuXi Biologics
Kymab
Ligand Pharmaceuticals
MorphoSys
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Discovery Platforms Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antigen Designing
1.2.3 Hit Generation
1.2.4 Lead Selection
1.2.5 Lead Optimization
1.2.6 Lead Characterization
1.2.7 Others
1.3 Market by Application
1.3.1 Global Antibody Discovery Platforms Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Institute of Biology
1.3.4 Therapeutic Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antibody Discovery Platforms Market Perspective (2017-2028)
2.2 Antibody Discovery Platforms Growth Trends by Region
2.2.1 Antibody Discovery Platforms Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antibody Discovery Platforms Historic Market Size by Region (2017-2022)
2.2.3 Antibody Discovery Platforms Forecasted Market Size by Region (2023-2028)
2.3 Antibody Discovery Platforms Market Dynamics
2.3.1 Antibody Discovery Platforms Industry Trends
2.3.2 Antibody Discovery Platforms Market Drivers
2.3.3 Antibody Discovery Platforms Market Challenges
2.3.4 Antibody Discovery Platforms Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Discovery Platforms Players by Revenue
3.1.1 Global Top Antibody Discovery Platforms Players by Revenue (2017-2022)
3.1.2 Global Antibody Discovery Platforms Revenue Market Share by Players (2017-2022)
3.2 Global Antibody Discovery Platforms Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Discovery Platforms Revenue
3.4 Global Antibody Discovery Platforms Market Concentration Ratio
3.4.1 Global Antibody Discovery Platforms Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Discovery Platforms Revenue in 2021
3.5 Antibody Discovery Platforms Key Players Head office and Area Served
3.6 Key Players Antibody Discovery Platforms Product Solution and Service
3.7 Date of Enter into Antibody Discovery Platforms Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Discovery Platforms Breakdown Data by Type
4.1 Global Antibody Discovery Platforms Historic Market Size by Type (2017-2022)
4.2 Global Antibody Discovery Platforms Forecasted Market Size by Type (2023-2028)
5 Antibody Discovery Platforms Breakdown Data by Application
5.1 Global Antibody Discovery Platforms Historic Market Size by Application (2017-2022)
5.2 Global Antibody Discovery Platforms Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antibody Discovery Platforms Market Size (2017-2028)
6.2 North America Antibody Discovery Platforms Market Size by Type
6.2.1 North America Antibody Discovery Platforms Market Size by Type (2017-2022)
6.2.2 North America Antibody Discovery Platforms Market Size by Type (2023-2028)
6.2.3 North America Antibody Discovery Platforms Market Share by Type (2017-2028)
6.3 North America Antibody Discovery Platforms Market Size by Application
6.3.1 North America Antibody Discovery Platforms Market Size by Application (2017-2022)
6.3.2 North America Antibody Discovery Platforms Market Size by Application (2023-2028)
6.3.3 North America Antibody Discovery Platforms Market Share by Application (2017-2028)
6.4 North America Antibody Discovery Platforms Market Size by Country
6.4.1 North America Antibody Discovery Platforms Market Size by Country (2017-2022)
6.4.2 North America Antibody Discovery Platforms Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Antibody Discovery Platforms Market Size (2017-2028)
7.2 Europe Antibody Discovery Platforms Market Size by Type
7.2.1 Europe Antibody Discovery Platforms Market Size by Type (2017-2022)
7.2.2 Europe Antibody Discovery Platforms Market Size by Type (2023-2028)
7.2.3 Europe Antibody Discovery Platforms Market Share by Type (2017-2028)
7.3 Europe Antibody Discovery Platforms Market Size by Application
7.3.1 Europe Antibody Discovery Platforms Market Size by Application (2017-2022)
7.3.2 Europe Antibody Discovery Platforms Market Size by Application (2023-2028)
7.3.3 Europe Antibody Discovery Platforms Market Share by Application (2017-2028)
7.4 Europe Antibody Discovery Platforms Market Size by Country
7.4.1 Europe Antibody Discovery Platforms Market Size by Country (2017-2022)
7.4.2 Europe Antibody Discovery Platforms Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Discovery Platforms Market Size (2017-2028)
8.2 Asia-Pacific Antibody Discovery Platforms Market Size by Type
8.2.1 Asia-Pacific Antibody Discovery Platforms Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antibody Discovery Platforms Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antibody Discovery Platforms Market Share by Type (2017-2028)
8.3 Asia-Pacific Antibody Discovery Platforms Market Size by Application
8.3.1 Asia-Pacific Antibody Discovery Platforms Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antibody Discovery Platforms Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antibody Discovery Platforms Market Share by Application (2017-2028)
8.4 Asia-Pacific Antibody Discovery Platforms Market Size by Region
8.4.1 Asia-Pacific Antibody Discovery Platforms Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antibody Discovery Platforms Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antibody Discovery Platforms Market Size (2017-2028)
9.2 Latin America Antibody Discovery Platforms Market Size by Type
9.2.1 Latin America Antibody Discovery Platforms Market Size by Type (2017-2022)
9.2.2 Latin America Antibody Discovery Platforms Market Size by Type (2023-2028)
9.2.3 Latin America Antibody Discovery Platforms Market Share by Type (2017-2028)
9.3 Latin America Antibody Discovery Platforms Market Size by Application
9.3.1 Latin America Antibody Discovery Platforms Market Size by Application (2017-2022)
9.3.2 Latin America Antibody Discovery Platforms Market Size by Application (2023-2028)
9.3.3 Latin America Antibody Discovery Platforms Market Share by Application (2017-2028)
9.4 Latin America Antibody Discovery Platforms Market Size by Country
9.4.1 Latin America Antibody Discovery Platforms Market Size by Country (2017-2022)
9.4.2 Latin America Antibody Discovery Platforms Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Discovery Platforms Market Size (2017-2028)
10.2 Middle East & Africa Antibody Discovery Platforms Market Size by Type
10.2.1 Middle East & Africa Antibody Discovery Platforms Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antibody Discovery Platforms Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antibody Discovery Platforms Market Share by Type (2017-2028)
10.3 Middle East & Africa Antibody Discovery Platforms Market Size by Application
10.3.1 Middle East & Africa Antibody Discovery Platforms Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antibody Discovery Platforms Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antibody Discovery Platforms Market Share by Application (2017-2028)
10.4 Middle East & Africa Antibody Discovery Platforms Market Size by Country
10.4.1 Middle East & Africa Antibody Discovery Platforms Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antibody Discovery Platforms Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abwiz Bio
11.1.1 Abwiz Bio Company Details
11.1.2 Abwiz Bio Business Overview
11.1.3 Abwiz Bio Antibody Discovery Platforms Introduction
11.1.4 Abwiz Bio Revenue in Antibody Discovery Platforms Business (2017-2022)
11.1.5 Abwiz Bio Recent Developments
11.2 Aragen Bioscience
11.2.1 Aragen Bioscience Company Details
11.2.2 Aragen Bioscience Business Overview
11.2.3 Aragen Bioscience Antibody Discovery Platforms Introduction
11.2.4 Aragen Bioscience Revenue in Antibody Discovery Platforms Business (2017-2022)
11.2.5 Aragen Bioscience Recent Developments
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Details
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Antibody Discovery Platforms Introduction
11.3.4 Creative Biolabs Revenue in Antibody Discovery Platforms Business (2017-2022)
11.3.5 Creative Biolabs Recent Developments
11.4 Distributed Bio
11.4.1 Distributed Bio Company Details
11.4.2 Distributed Bio Business Overview
11.4.3 Distributed Bio Antibody Discovery Platforms Introduction
11.4.4 Distributed Bio Revenue in Antibody Discovery Platforms Business (2017-2022)
11.4.5 Distributed Bio Recent Developments
11.5 ImmunoPrecise Antibodies
11.5.1 ImmunoPrecise Antibodies Company Details
11.5.2 ImmunoPrecise Antibodies Business Overview
11.5.3 ImmunoPrecise Antibodies Antibody Discovery Platforms Introduction
11.5.4 ImmunoPrecise Antibodies Revenue in Antibody Discovery Platforms Business (2017-2022)
11.5.5 ImmunoPrecise Antibodies Recent Developments
11.6 Integral Molecular
11.6.1 Integral Molecular Company Details
11.6.2 Integral Molecular Business Overview
11.6.3 Integral Molecular Antibody Discovery Platforms Introduction
11.6.4 Integral Molecular Revenue in Antibody Discovery Platforms Business (2017-2022)
11.6.5 Integral Molecular Recent Developments
11.7 LakePharma
11.7.1 LakePharma Company Details
11.7.2 LakePharma Business Overview
11.7.3 LakePharma Antibody Discovery Platforms Introduction
11.7.4 LakePharma Revenue in Antibody Discovery Platforms Business (2017-2022)
11.7.5 LakePharma Recent Developments
11.8 Syd Labs
11.8.1 Syd Labs Company Details
11.8.2 Syd Labs Business Overview
11.8.3 Syd Labs Antibody Discovery Platforms Introduction
11.8.4 Syd Labs Revenue in Antibody Discovery Platforms Business (2017-2022)
11.8.5 Syd Labs Recent Developments
11.9 Abzena
11.9.1 Abzena Company Details
11.9.2 Abzena Business Overview
11.9.3 Abzena Antibody Discovery Platforms Introduction
11.9.4 Abzena Revenue in Antibody Discovery Platforms Business (2017-2022)
11.9.5 Abzena Recent Developments
11.10 BIOTEM
11.10.1 BIOTEM Company Details
11.10.2 BIOTEM Business Overview
11.10.3 BIOTEM Antibody Discovery Platforms Introduction
11.10.4 BIOTEM Revenue in Antibody Discovery Platforms Business (2017-2022)
11.10.5 BIOTEM Recent Developments
11.11 PX’Therapeutics
11.11.1 PX’Therapeutics Company Details
11.11.2 PX’Therapeutics Business Overview
11.11.3 PX’Therapeutics Antibody Discovery Platforms Introduction
11.11.4 PX’Therapeutics Revenue in Antibody Discovery Platforms Business (2017-2022)
11.11.5 PX’Therapeutics Recent Developments
11.12 ChemPartner
11.12.1 ChemPartner Company Details
11.12.2 ChemPartner Business Overview
11.12.3 ChemPartner Antibody Discovery Platforms Introduction
11.12.4 ChemPartner Revenue in Antibody Discovery Platforms Business (2017-2022)
11.12.5 ChemPartner Recent Developments
11.13 HD Biosciences
11.13.1 HD Biosciences Company Details
11.13.2 HD Biosciences Business Overview
11.13.3 HD Biosciences Antibody Discovery Platforms Introduction
11.13.4 HD Biosciences Revenue in Antibody Discovery Platforms Business (2017-2022)
11.13.5 HD Biosciences Recent Developments
11.14 Viva Biotech
11.14.1 Viva Biotech Company Details
11.14.2 Viva Biotech Business Overview
11.14.3 Viva Biotech Antibody Discovery Platforms Introduction
11.14.4 Viva Biotech Revenue in Antibody Discovery Platforms Business (2017-2022)
11.14.5 Viva Biotech Recent Developments
11.15 WuXi Biologics
11.15.1 WuXi Biologics Company Details
11.15.2 WuXi Biologics Business Overview
11.15.3 WuXi Biologics Antibody Discovery Platforms Introduction
11.15.4 WuXi Biologics Revenue in Antibody Discovery Platforms Business (2017-2022)
11.15.5 WuXi Biologics Recent Developments
11.16 Kymab
11.16.1 Kymab Company Details
11.16.2 Kymab Business Overview
11.16.3 Kymab Antibody Discovery Platforms Introduction
11.16.4 Kymab Revenue in Antibody Discovery Platforms Business (2017-2022)
11.16.5 Kymab Recent Developments
11.17 Ligand Pharmaceuticals
11.17.1 Ligand Pharmaceuticals Company Details
11.17.2 Ligand Pharmaceuticals Business Overview
11.17.3 Ligand Pharmaceuticals Antibody Discovery Platforms Introduction
11.17.4 Ligand Pharmaceuticals Revenue in Antibody Discovery Platforms Business (2017-2022)
11.17.5 Ligand Pharmaceuticals Recent Developments
11.18 MorphoSys
11.18.1 MorphoSys Company Details
11.18.2 MorphoSys Business Overview
11.18.3 MorphoSys Antibody Discovery Platforms Introduction
11.18.4 MorphoSys Revenue in Antibody Discovery Platforms Business (2017-2022)
11.18.5 MorphoSys Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Antibody Discovery Platforms Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Antigen Designing
Table 3. Key Players of Hit Generation
Table 4. Key Players of Lead Selection
Table 5. Key Players of Lead Optimization
Table 6. Key Players of Lead Characterization
Table 7. Key Players of Others
Table 8. Global Antibody Discovery Platforms Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Antibody Discovery Platforms Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Antibody Discovery Platforms Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Antibody Discovery Platforms Market Share by Region (2017-2022)
Table 12. Global Antibody Discovery Platforms Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Antibody Discovery Platforms Market Share by Region (2023-2028)
Table 14. Antibody Discovery Platforms Market Trends
Table 15. Antibody Discovery Platforms Market Drivers
Table 16. Antibody Discovery Platforms Market Challenges
Table 17. Antibody Discovery Platforms Market Restraints
Table 18. Global Antibody Discovery Platforms Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Antibody Discovery Platforms Revenue Share by Players (2017-2022)
Table 20. Global Top Antibody Discovery Platforms by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Discovery Platforms as of 2021)
Table 21. Ranking of Global Top Antibody Discovery Platforms Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Antibody Discovery Platforms Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antibody Discovery Platforms Product Solution and Service
Table 25. Date of Enter into Antibody Discovery Platforms Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antibody Discovery Platforms Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Antibody Discovery Platforms Revenue Market Share by Type (2017-2022)
Table 29. Global Antibody Discovery Platforms Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Antibody Discovery Platforms Revenue Market Share by Type (2023-2028)
Table 31. Global Antibody Discovery Platforms Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Antibody Discovery Platforms Revenue Share by Application (2017-2022)
Table 33. Global Antibody Discovery Platforms Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Antibody Discovery Platforms Revenue Share by Application (2023-2028)
Table 35. North America Antibody Discovery Platforms Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Antibody Discovery Platforms Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Antibody Discovery Platforms Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Antibody Discovery Platforms Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Antibody Discovery Platforms Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Antibody Discovery Platforms Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Antibody Discovery Platforms Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Antibody Discovery Platforms Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Antibody Discovery Platforms Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Antibody Discovery Platforms Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Antibody Discovery Platforms Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Antibody Discovery Platforms Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Antibody Discovery Platforms Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Antibody Discovery Platforms Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Antibody Discovery Platforms Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Antibody Discovery Platforms Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Antibody Discovery Platforms Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Antibody Discovery Platforms Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Antibody Discovery Platforms Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Antibody Discovery Platforms Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Antibody Discovery Platforms Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Antibody Discovery Platforms Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Antibody Discovery Platforms Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Antibody Discovery Platforms Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Antibody Discovery Platforms Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Antibody Discovery Platforms Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Antibody Discovery Platforms Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Antibody Discovery Platforms Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Antibody Discovery Platforms Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Antibody Discovery Platforms Market Size by Country (2023-2028) & (US$ Million)
Table 65. Abwiz Bio Company Details
Table 66. Abwiz Bio Business Overview
Table 67. Abwiz Bio Antibody Discovery Platforms Product
Table 68. Abwiz Bio Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 69. Abwiz Bio Recent Developments
Table 70. Aragen Bioscience Company Details
Table 71. Aragen Bioscience Business Overview
Table 72. Aragen Bioscience Antibody Discovery Platforms Product
Table 73. Aragen Bioscience Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 74. Aragen Bioscience Recent Developments
Table 75. Creative Biolabs Company Details
Table 76. Creative Biolabs Business Overview
Table 77. Creative Biolabs Antibody Discovery Platforms Product
Table 78. Creative Biolabs Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 79. Creative Biolabs Recent Developments
Table 80. Distributed Bio Company Details
Table 81. Distributed Bio Business Overview
Table 82. Distributed Bio Antibody Discovery Platforms Product
Table 83. Distributed Bio Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 84. Distributed Bio Recent Developments
Table 85. ImmunoPrecise Antibodies Company Details
Table 86. ImmunoPrecise Antibodies Business Overview
Table 87. ImmunoPrecise Antibodies Antibody Discovery Platforms Product
Table 88. ImmunoPrecise Antibodies Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 89. ImmunoPrecise Antibodies Recent Developments
Table 90. Integral Molecular Company Details
Table 91. Integral Molecular Business Overview
Table 92. Integral Molecular Antibody Discovery Platforms Product
Table 93. Integral Molecular Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 94. Integral Molecular Recent Developments
Table 95. LakePharma Company Details
Table 96. LakePharma Business Overview
Table 97. LakePharma Antibody Discovery Platforms Product
Table 98. LakePharma Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 99. LakePharma Recent Developments
Table 100. Syd Labs Company Details
Table 101. Syd Labs Business Overview
Table 102. Syd Labs Antibody Discovery Platforms Product
Table 103. Syd Labs Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 104. Syd Labs Recent Developments
Table 105. Abzena Company Details
Table 106. Abzena Business Overview
Table 107. Abzena Antibody Discovery Platforms Product
Table 108. Abzena Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 109. Abzena Recent Developments
Table 110. BIOTEM Company Details
Table 111. BIOTEM Business Overview
Table 112. BIOTEM Antibody Discovery Platforms Product
Table 113. BIOTEM Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 114. BIOTEM Recent Developments
Table 115. PX'Therapeutics Company Details
Table 116. PX'Therapeutics Business Overview
Table 117. PX'Therapeutics Antibody Discovery Platforms Product
Table 118. PX'Therapeutics Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 119. PX'Therapeutics Recent Developments
Table 120. ChemPartner Company Details
Table 121. ChemPartner Business Overview
Table 122. ChemPartner Antibody Discovery Platforms Product
Table 123. ChemPartner Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 124. ChemPartner Recent Developments
Table 125. HD Biosciences Company Details
Table 126. HD Biosciences Business Overview
Table 127. HD Biosciences Antibody Discovery Platforms Product
Table 128. HD Biosciences Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 129. HD Biosciences Recent Developments
Table 130. Viva Biotech Company Details
Table 131. Viva Biotech Business Overview
Table 132. Viva Biotech Antibody Discovery Platforms Product
Table 133. Viva Biotech Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 134. Viva Biotech Recent Developments
Table 135. WuXi Biologics Company Details
Table 136. WuXi Biologics Business Overview
Table 137. WuXi Biologics Antibody Discovery Platforms Product
Table 138. WuXi Biologics Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 139. WuXi Biologics Recent Developments
Table 140. Kymab Company Details
Table 141. Kymab Business Overview
Table 142. Kymab Antibody Discovery Platforms Product
Table 143. Kymab Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 144. Kymab Recent Developments
Table 145. Ligand Pharmaceuticals Company Details
Table 146. Ligand Pharmaceuticals Business Overview
Table 147. Ligand Pharmaceuticals Antibody Discovery Platforms Product
Table 148. Ligand Pharmaceuticals Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 149. Ligand Pharmaceuticals Recent Developments
Table 150. MorphoSys Company Details
Table 151. MorphoSys Business Overview
Table 152. MorphoSys Antibody Discovery Platforms Product
Table 153. MorphoSys Revenue in Antibody Discovery Platforms Business (2017-2022) & (US$ Million)
Table 154. MorphoSys Recent Developments
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Discovery Platforms Market Share by Type: 2021 VS 2028
Figure 2. Antigen Designing Features
Figure 3. Hit Generation Features
Figure 4. Lead Selection Features
Figure 5. Lead Optimization Features
Figure 6. Lead Characterization Features
Figure 7. Others Features
Figure 8. Global Antibody Discovery Platforms Market Share by Application: 2021 VS 2028
Figure 9. Pharmaceutical Case Studies
Figure 10. Institute of Biology Case Studies
Figure 11. Therapeutic Research Case Studies
Figure 12. Others Case Studies
Figure 13. Antibody Discovery Platforms Report Years Considered
Figure 14. Global Antibody Discovery Platforms Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Antibody Discovery Platforms Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Antibody Discovery Platforms Market Share by Region: 2021 VS 2028
Figure 17. Global Antibody Discovery Platforms Market Share by Players in 2021
Figure 18. Global Top Antibody Discovery Platforms Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Discovery Platforms as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Antibody Discovery Platforms Revenue in 2021
Figure 20. North America Antibody Discovery Platforms Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Antibody Discovery Platforms Market Size Market Share by Type (2017-2028)
Figure 22. North America Antibody Discovery Platforms Market Size Market Share by Application (2017-2028)
Figure 23. North America Antibody Discovery Platforms Market Size Share by Country (2017-2028)
Figure 24. United States Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Antibody Discovery Platforms Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Antibody Discovery Platforms Market Size Market Share by Type (2017-2028)
Figure 28. Europe Antibody Discovery Platforms Market Size Market Share by Application (2017-2028)
Figure 29. Europe Antibody Discovery Platforms Market Size Share by Country (2017-2028)
Figure 30. Germany Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Antibody Discovery Platforms Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Antibody Discovery Platforms Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Antibody Discovery Platforms Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Antibody Discovery Platforms Market Size Share by Region (2017-2028)
Figure 40. China Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Antibody Discovery Platforms Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Antibody Discovery Platforms Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Antibody Discovery Platforms Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Antibody Discovery Platforms Market Size Share by Country (2017-2028)
Figure 50. Mexico Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Antibody Discovery Platforms Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Antibody Discovery Platforms Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Antibody Discovery Platforms Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Antibody Discovery Platforms Market Size Share by Country (2017-2028)
Figure 56. Turkey Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Antibody Discovery Platforms Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Abwiz Bio Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 60. Aragen Bioscience Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 61. Creative Biolabs Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 62. Distributed Bio Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 63. ImmunoPrecise Antibodies Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 64. Integral Molecular Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 65. LakePharma Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 66. Syd Labs Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 67. Abzena Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 68. BIOTEM Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 69. PX'Therapeutics Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 70. ChemPartner Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 71. HD Biosciences Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 72. Viva Biotech Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 73. WuXi Biologics Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 74. Kymab Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 75. Ligand Pharmaceuticals Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 76. MorphoSys Revenue Growth Rate in Antibody Discovery Platforms Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

以下、関連資料のご紹介

AFMポリクローナル抗体のグローバル市場インサイト・予測（～2028年）

Global AFM Polyclonal Antibody Market Insights, Forecast to 2028
QY2207E09409 2022年7月 110Pages
新型コロナウイルス感染症のパンデミックにより、世界のAFMポリクローナル抗体の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にAFMポリク...

二重特異性＆三重特異性抗体のグローバル市場インサイト・予測（～2028年）

Global Bispecific and Trispecific Antibody Market Insights, Forecast to 2028
QY2207E09207 2022年7月 110Pages
新型コロナウイルス感染症のパンデミックにより、世界の二重特異性＆三重特異性抗体の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に二重特異性...

エッジAIプラットフォームのグローバル市場インサイト・予測（～2028年）

Global Edge AI Platforms Market Insights, Forecast to 2028
QY2207C2078 2022年7月8日 110Pages
新型コロナウイルス感染症のパンデミックにより、世界のエッジAIプラットフォームの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にエッジAI...

マイコプラズマ肺炎IgG/IgM抗体検査キットのグローバル市場インサイト・予測（～2028年）

Global Mycoplasma Pneumoniae IgG/IgM Antibody Test Kit Market Insights, Forecast to 2028
QY2207E09858 2022年7月 112Pages
新型コロナウイルス感染症のパンデミックにより、世界のマイコプラズマ肺炎IgG/IgM抗体検査キットの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2...

ヘキサポッドプレシジョンモーションプラットフォームのグローバル市場インサイト・予測（～2028年）

Global Hexapod Precision Motion Platforms Market Insights, Forecast to 2028
QY2207E06336 2022年7月 110Pages
新型コロナウイルス感染症のパンデミックにより、世界のヘキサポッドプレシジョンモーションプラットフォームの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると...

AFMポリクローナル抗体のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global AFM Polyclonal Antibody Market The global AFM Polyclonal Antibody market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Goat accounting for % …
血中鉛分析装置のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Blood Lead Analyzer Market Due to the COVID-19 pandemic, the global Blood Lead Analyzer market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Ful…
二重特異性＆三重特異性抗体のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Bispecific and Trispecific Antibody Market The global Bispecific and Trispecific Antibody market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis…
鉛塗料分析装置のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Lead-paint Analyzer Market Due to the COVID-19 pandemic, the global Lead-paint Analyzer market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Ful…
XRF鉛系塗料分析装置のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global XRF Lead-Based Paint Analyzer Market Due to the COVID-19 pandemic, the global XRF Lead-Based Paint Analyzer market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast p…